The Central Drugs Standard Control Organisation (CDSCO) has launched a probe after the World Health Organisation issued an alert against four India-made cold and cough syrups that have been "potentially linked" with acute kidney injuries and 66 deaths among children in the African country, The Gambia.
According to government sources, CDSCO has taken up the matter and ordered a detailed investigation against the cough and cold syrups produced and exported to The Gambia by Maiden Pharmaceuticals Limited, which is based in Haryana's Sonepat, on the basis of available information shared by WHO.
